Related Articles
The circulating auto-antibodies to p53 protein in the follow-up of lymphoma patients.
Rituximab in combination with platinum-containing chemotherapy in patients with relapsed or primary refractory diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
Predictive significance of the cut-off value of CD20 expression in patients with B-cell lymphoma
Diagnostic value of immunoglobulin κ light chain gene rearrangement analysis in B-cell lymphomas